Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Richard Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4743-5568; OpenAlex author ID A5054161353. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. Pancreatic Cancer-Advances in the Last 50 Years. Co-author DOI 10.1002/wjs.70309↗
  2. Survival Impact of Intraoperative Carbon Dioxide Dysregulation in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/xcs.0000000000001760↗
  3. P53 Function Status Correlates With Overall Survival in Patients With Resected Pancreatic Cancer. Co-author DOI 10.1002/jso.70060↗
  4. Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer. First author DOI 10.1016/j.hpb.2024.07.403↗
  5. Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer. Co-author DOI 10.1093/gastro/goaa084↗
  6. Margin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival. Co-author DOI 10.1245/s10434-020-09000-9↗
  7. ASO Author Reflections: Margin-Positive Pancreatic Ductal Adenocarcinoma During Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival. Co-author DOI 10.1245/s10434-020-09031-2↗
  8. Validation of American Joint Committee on Cancer 8th edition of TNM staging in resected distal pancreatic cancer. Co-author DOI 10.4292/wjgpt.v11.i2.25↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Charles J. Yeo · 5 shared papers, 2020–2026 · strength 1.14
  2. Harish Lavu · 4 shared papers, 2020–2026 · strength 0.78
  3. Avinoam Nevler · 2 shared papers, 2025–2026 · strength 0.54
  4. Christopher William Schultz · 4 shared papers, 2020–2021 · strength 0.42
  5. Savio George Barreto · 1 shared paper, 2026 · strength 0.36
  6. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.36
  7. Anirban Maitra · 1 shared paper, 2026 · strength 0.36
  8. Dushyant V. Sahani · 1 shared paper, 2026 · strength 0.36
  9. Ashley Wetzel · 1 shared paper, 2026 · strength 0.29
  10. Nader N Hanna · 1 shared paper, 2026 · strength 0.29
  11. Andrea Feci · 1 shared paper, 2026 · strength 0.29
  12. Aditi Jain · 1 shared paper, 2025 · strength 0.26
  13. Hui Chen · 1 shared paper, 2025 · strength 0.26
  14. David O. Nauheim · 2 shared papers, 2020–2021 · strength 0.24
  15. Adam C. Berger · 2 shared papers, 2020–2021 · strength 0.24
  16. Christopher R. Shubert · 1 shared paper, 2024 · strength 0.23
  17. Fabian Mc. Johnston · 1 shared paper, 2024 · strength 0.23
  18. William R. Burns · 1 shared paper, 2024 · strength 0.23
  19. Kelly J. Lafaro · 1 shared paper, 2024 · strength 0.23
  20. Richard Andrew Burkhart · 1 shared paper, 2024 · strength 0.23
  21. Andy Tran · 1 shared paper, 2024 · strength 0.23
  22. Teena Dhir · 2 shared papers, 2020–2021 · strength 0.19
  23. Xiuli Liu · 2 shared papers, 2020–2021 · strength 0.19
  24. Xuefeng Zhang · 2 shared papers, 2020–2021 · strength 0.19
  25. Hao Xie · 2 shared papers, 2020–2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.